U.S. Withdrawal from the World Health Organization
President Trump has quickly moved to formally withdraw the United States from the World Health Organization (WHO) with an executive order signed on January 20th. This decision echoes his earlier approach during his first term, where he aimed to cut funding and sever ties with the organization.
The administration has framed the withdrawal as a way to safeguard American interests, including taxpayer dollars and global health. Historically, the U.S. has been a significant contributor to the WHO, funding around 20% of its $6.8 billion biennial budget. Now, the loss of this support places WHO Director-General Tedros Adhanom Ghebreyesus in a tough spot since he’s losing his largest donor. He has urged Trump to reconsider, mentioning the importance of donations being viewed as investments in safety rather than charity.
The official exit will occur in January, but Tedros believes there’s still a chance to win Trump over. Yet, the fraught relationship with the WHO complicates things. There’s been longstanding criticism that the WHO tends to favor China, especially in light of the recent pandemic. China is the second-largest donor, contributing about 16% to the organization’s budget.
When the pandemic struck in early 2020, Tedros lauded China’s response, which some viewed as neglecting to criticize its handling of the outbreak. He later indicated that China is unhappy with the WHO’s stance regarding the origins of the virus, suggesting that “all hypotheses are on the table,” including potential lab leaks.
Funding suspensions aren’t solely about the U.S.-China dynamic; the WHO has faced backlash for its perceived inefficiency. Reports have surfaced about the organization spending more on travel than on vital health crises like AIDS and malaria. Critics have pointed out expenditures like over $1,000-a-night hotel stays, leading to public outrage. Dr. Ashish Jha from Brown University remarked that extravagant travel expenses challenge the WHO’s credibility when soliciting funding.
Furthermore, concerns have surfaced over the distribution of vaccines through the WHO’s COVAX program. Reports have indicated issues with fraud and a lack of transparency regarding pricing, raising doubts about decision-making processes during critical times. An informant stated that it’s tough to analyze these decisions without clear information about costs and options.
Despite the setbacks, Tedros still hopes for continued financial support from the U.S., although significant losses loom for the organization amid these changes.
